Company intelligence / Profile preview
Changzhou Siyao Pharmaceuticals
常州, 江苏省, 中国czsiyao-pharm.com ↗
- Ownership
- Private
- Employees
- ~11
- Development stage
- Commercial
01
Overview
Changzhou Siyao Pharmaceuticals is a cGMP-compliant pharmaceutical company with FDA approval and CEP certifications. It develops and manufactures over 20 active pharmaceutical ingredients (APIs) and more than 100 finished products across multiple therapeutic areas. The company exports globally to the USA, Europe, Southeast Asia, and other regions. Its main APIs include ambroxol hydrochloride (for respiratory conditions), bromazepam and chlordiazepoxide hydrochloride (psychotropics), cyproheptadine hydrochloride (antihistamine), omeprazole (digestive), fluoxetine hydrochloride (antidepressant), among others. The company has a record of regulatory inspections including by the FDA.
- Therapeutic areas
- PulmonologyEndocrinologyImmunologyPsychiatryGastroenterologyCardiovascular
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Jiaxing Xinwen Biotechnology Co., Ltd.: Technical entrustment development contract for transdermal drug delivery technology research collaboration.
Beyond the preview
Go deeper on Changzhou Siyao Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Changzhou Siyao Pharmaceuticals.